Should all Australian children be vaccinated against influenza?

David Isaacs
Med J Aust 2005; 182 (11): . || doi: 10.5694/j.1326-5377.2005.tb06811.x
Published online: 6 June 2005

Questions of cost-effectiveness, vaccine efficacy and feasibility are yet to be answered

In the United States, routine immunisation of all healthy children aged 6–23 months against influenza has recently been introduced. The principal justification for this is the relatively high morbidity and mortality from this disease in very young children.1 The United States is also considering routine influenza immunisation of all children aged over 6 months, in view of the herd protection it would provide to the adult population.

  • David Isaacs

  • Department of Allergy, Immunology and Infectious Diseases, Children’s Hospital at Westmead, Westmead, NSW.



I thank Professor Peter McIntyre, Director of the National Centre for Immunisation Research and Surveillance, for his helpful suggestions on the manuscript.

Competing interests:

Gerald Watts is a member of the advisory boards for Merck Sharp and Dohme, Pfizer and AstraZeneca in Australia.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.